Autoimmune Disease Diagnostics
Middle East
Updated
Reviewed by Chandani Patel
Middle East Drug Delivery Devices Market Industry Trends and Forecast to 2034: Segmented by (Route, Product, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$2.29 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $2.20 Bn | — | — |
| 2025 (base) | $2.37 Bn | +$171.6 Mn | — |
| 2026 (forecast) | $2.56 Bn | +$184.9 Mn | +7.8% |
| 2027 (forecast) | $2.76 Bn | +$199.4 Mn | +16.2% |
| 2028 (forecast) | $2.97 Bn | +$214.9 Mn | +25.3% |
| 2029 (forecast) | $3.20 Bn | +$231.7 Mn | +35% |
| 2030 (forecast) | $3.45 Bn | +$249.7 Mn | +45.6% |
| 2031 (forecast) | $3.72 Bn | +$269.2 Mn | +56.9% |
| 2032 (forecast) | $4.01 Bn | +$290.2 Mn | +69.2% |
| 2033 (forecast) | $4.32 Bn | +$312.9 Mn | +82.4% |
| 2034 (forecast) | $4.66 Bn | +$337.3 Mn | +96.6% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $2.37 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $4.66 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Route and product (see all) |
| Key players | BD (Becton, Dickinson), Gerresheimer, West Pharmaceutical Services, Ypsomed, Terumo Corporation and 1 more (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Drug delivery devices give medicine in a controlled way, such as injectors, inhalers, patches and infusion pumps.
Key segments of the drug delivery devices market include route (Injectable, Inhalation and Transdermal) and product (Auto-Injectors, Pen Injectors and Inhalers).
Rising numbers of people with diabetes, a shift to tools that track and deliver treatment automatically, and more insurance cover are driving the drug delivery devices market.
Connected devices, lower-priced sensors and new insulins and pills give the drug delivery devices market room to grow.
High costs for people without cover, price competition and uneven access to care in low-income countries hold back the drug delivery devices market.
The drug delivery devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medical devices are regulated by SFDA (Saudi Arabia)[1], EDE (UAE)[2], Ministry of Public Health (Qatar)[3] and AMAR (Israel)[4]. How care is paid for in some of these countries: free public care and CHI-regulated insurance (Saudi Arabia)[5], mandatory health insurance (UAE)[6], public care and compulsory insurance (Qatar)[3] and four health funds (Israel)[4].
[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.
[2] Emirates Drug Establishment. Checked 14 Nov 2026.
[3] Ministry of Public Health, Qatar. Checked 19 Nov 2026.
[4] Israel Ministry of Health. Checked 19 Nov 2026.
[5] Council of Health Insurance. Checked 14 Nov 2026.
[6] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how drug delivery devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Middle East.
What doctors and scientists are doing in Drug Delivery Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Middle East
Middle East
Middle East
Middle East
Middle East
Middle East
Pharmaceuticals · Middle East
Pharmaceuticals · Middle East
Healthcare Services · Middle East
Healthcare Services · Middle East
Healthcare Services · Middle East
Healthcare Services · Middle East